比较断层合成联合乳腺X线摄影与单独乳腺X线摄影后乳腺癌发病率和间期癌的随机试验
RETomo前瞻性随机试验将筛查女性分为一轮数字乳腺断层合成(DBT)联合数字乳腺X线摄影(DM)组或单独DM组,12或24个月后均用DM复筛。DBT+DM组基线癌症检出率更高(相对检出1.7,95%CI 1.2-2.3),但间期癌发病率相似(相对发病0.97,95%CI 0.53-1.8)。50岁以上女性DBT+DM组累积发病率仍较高(相对发病1.2,95%CI 0.99-1.6),45-49岁两组相似(相对发病0.89,95%CI 0.57-1.4)。
要点
- DBT+DM组基线癌症检出101/13356例,DM组61/13521例,相对检出1.7(95%CI 1.2-2.3)。
- 两组间期癌发病相似:DBT+DM组21例 vs DM组22例,相对发病0.97(95%CI 0.53-1.8)。
- 50岁以上女性DBT+DM组累积发病153例 vs DM组124例,相对发病1.2(95%CI 0.99-1.6)。
核心结论
- 在50岁以下女性中,早期诊断的获益似乎可观;而对于50岁以上女性,断层合成联合乳腺X线摄影的更高敏感度并未带来下一轮筛查或间期内癌症的后续减少。
研究设计与样本
- 前瞻性随机试验(RETomo),女性随机接受一轮DBT+DM(实验组)或DM(对照组),随后在12个月(45-49岁)或24个月(50-69岁)后用DM复筛;共13356例(DBT+DM组)和13521例(DM组)女性,两组平均年龄55岁±7岁;主要结局为间期癌发病率。
诊断标准与关键数值
- 基线癌症检出:DBT+DM组101/13356例 vs DM组61/13521例,相对检出1.7(95%CI 1.2, 2.3)。
- 间期癌发病率:DBT+DM组21例 vs DM组22例,相对发病0.97(95%CI 0.53, 1.8)。
- 50岁以上女性累积发病率:DBT+DM组153例 vs DM组124例,相对发病1.2(95%CI 0.99, 1.6)。
- 45-49岁女性累积发病率:DBT+DM组36例 vs DM组41例,相对发病0.89(95%CI 0.57, 1.4)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Adding digital breast tomosynthesis (DBT) to digital mammography (DM) improves breast cancer screening sensitivity, but how this impacts mortality and other end points is unknown. Purpose To compare interval and overall breast cancer incidence after screening with DBT plus DM versus DM alone. Materials and Methods In this prospective trial (RETomo), women attending screening were randomized to one round of DBT plus DM (experimental arm) or to DM (control arm). All were then rescreened with DM after 12 months (women aged 45-49 years) or after 24 months (50-69 years). The primary outcome was interval cancer incidence. Cumulative incidence up to the subsequent screening round plus 9 months (21- and 33-month follow-up for women aged 45-49 and 50-69, respectively) was also reported. Ductal carcinomas in situ are included. Subgroup analyses by age and breast density were conducted; 95% CIs computed according to binomial distribution are reported. Results Baseline cancer detection was higher in the DBT plu DM arm than DM arm (101 of 13 356 women vs 61 of 13 521 women; relative detection, 1.7 [95% CI: 1.2, 2.3]). The mean age ± standard deviation for the women in both arms was 55 years ± 7. Interval cancer incidence was similar in the two arms (21 vs 22 cancers; relative incidence, 0.97 [95% CI: 0.53, 1.8]). Cumulative incidence remained higher in the DBT plus DM arm in women over 50 (153 vs 124 cancers; relative incidence, 1.2 [95% CI: 0.99, 1.6]), while it was similar in the two arms in women aged 45-49 (36 vs 41 cancers; relative incidence, 0.89 [95% CI: 0.57, 1.4]). Conclusion In women younger than 50 years, the benefit of early diagnosis seemed to be appreciable, while for women over age 50, the higher sensitivity of tomosynthesis plus mammography was not matched by a subsequent reduction in cancers at the next screening examination or in the intervening interval. Clinical trial registration no. NCT02698202 © RSNA, 2022 Online supplemental material is available for this article. See also the editorial by Lee and Ray in this issue.
引用
- Pattacini, Nitrosi, Giorgi Rossi, et al. A Randomized Trial Comparing Breast Cancer Incidence and Interval Cancers after Tomosynthesis Plus Mammography versus Mammography Alone. Radiology. 2022. PMID: 35103537. doi:10.1148/radiol.211132
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。